ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Sodium hydride → (R)-7-chloro-5,11-dihydro-5-[1-(3,4-methylenedioxyphenethyl)pyrrolidin-2-ylmethyl]-dibenzo[b,e][1,4]oxazepine

HRID 2251879
ノート
印刷プレビュー

反応式

HRID 2251879 の反応式
[H-].[Na+].[Cl:3][C:4]1[CH:18]=[CH:17][C:7]2[O:8][CH2:9][C:10]3[CH:16]=[CH:15][CH:14]=[CH:13][C:11]=3[NH:12][C:6]=2[CH:5]=1.Cl[C@@H:20]1[CH2:25][CH2:24][CH2:23][N:22]([CH2:26][CH2:27][C:28]2[CH:33]=[CH:32][C:31]3[O:34][CH2:35][O:36][C:30]=3[CH:29]=2)[CH2:21]1.C(=O)([O-])O.[Na+]>CCCCCC.CS(C)=O.C(OCC)(=O)C>[Cl:3][C:4]1[CH:18]=[CH:17][C:7]2[O:8][CH2:9][C:10]3[CH:16]=[CH:15][CH:14]=[CH:13][C:11]=3[N:12]([CH2:24][C@H:23]3[CH2:25][CH2:20][CH2:21][N:22]3[CH2:26][CH2:27][C:28]3[CH:33]=[CH:32][C:31]4[O:34][CH2:35][O:36][C:30]=4[CH:29]=3)[C:6]=2[CH:5]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 24758Sodium hydrideHCID 516892Sodium BicarbonateHCID 15481949(R)-3-chloro-1-(3,4-methylenedioxyphenethyl)piperidineHCID 218222787-Chloro-5,11-dihydrodibenzo[b,e][1,4]oxazepine

生成物 1

HCID 59643983(R)-7-chloro-5,11-dihydro-5-[1-(3,4-methylenedioxyphenethyl)pyrrolidin-2-ylmethyl]-dibenzo[b,e][1,4]oxazepine

試薬・触媒・溶媒 3

HCID 679
Dimethyl Sulfoxide
溶媒
2 回
HCID 8058Hexane溶媒
HCID 8857Ethyl Acetate溶媒

実験手順

60% sodium hydride (48 mg, 1.2 mmol) was washed with hexane in argon gas stream and then suspended in dimethyl sulfoxide (8 ml). The obtained suspension was stirred at room temperature for 30 minutes. 7-Chloro-5,11-dihydrodibenzo[b,e][1,4]oxazepine (232 mg, 1 mmol) was added to the suspension, and they were stirred at room temperature for 30 minutes and then at 50° C. for 30 minutes. A solution of (R)-3-chloro-1-(3,4-methylenedioxyphenethyl)piperidine (308 mg, 1.15 mmol) in dimethyl sulfoxide (3 ml) was added dropwise to the obtained solution, and they were stirred at 50° C. for 4 hours. The reaction mixture was distributed into saturated aqueous sodium hydrogencarbonate solution and ethyl acetate. The organic layer was dried and the solvent was evaporated under reduced pressure. The residue was subjected to the silica gel column chromatography. After the elution with hexane and ethyl acetate (10:1) as the eluent, suitable fractions were collected and the solvent was evaporated under reduced pressure to obtain (R)-7-chloro-5,11-dihydro-5-[1-(3,4-methylenedioxyphenethyl)pyrrolidin-2-ylmethyl]-dibenzo[b,e][1,4]oxazepine in the form of a light yellow solid (362 mg, 78%).

後処理

  1. stirringwere stirred at room temperature for 30 minutes
  2. waitat 50° C. for 30 minutes
  3. stirringwere stirred at 50° C. for 4 hours
  4. customThe organic layer was dried
  5. customthe solvent was evaporated under reduced pressure
  6. washAfter the elution with hexane and ethyl acetate (10:1) as the eluent, suitable fractions
  7. customwere collected
  8. customthe solvent was evaporated under reduced pressure

出典と根拠

ORDレコード
ord-e846c64d06244c168820fc07c0cb9c24
出典データセット
uspto-grants-2008_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07320973B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート